Case Studies

Myovant Sciences and Evidation survey explores lived experiences and unseen burdens of women and individuals with endometriosis and uterine fibroids

Read findings from Evidation and Myovant surrounding the impact of endometriosis and/or uterine fibroids on work, school, and activities of daily living.

Supporting conversations at the point of care with personalized health insights

Read this case study to learn about how Evidation enables individuals to better understand and act on their heart health outside of clinical settings.

Increasing treatment rates with co-created patient engagement

Read this case study to learn how Evidation increased vaccination rates through customized messages and content.

Individuals diagnosed with breast cancer or in remission self-report QoL

Person-generated health data (PGHD) shows promise in detecting cognitive impairment & informing therapies.

COPD — Determine high-impact clinical markers with person-generated health data (PGHD)

Combining activity and behavioral-related data can predict exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients

Rheumatoid Arthritis — The pandemic’s impact on Rx adherence & access to care

Non-adherence to medication & unwillingness to visit health facilities soar due to COVID-19.

Asthma — PGHD delivers a roadmap to optimal treatment

Person-generated health data (PGHD) allows users to identify and segment patients based on real world behaviors and disease impact.

Multiple Sclerosis — Wearable data can assess MS patients’ disease activity

Evaluating minute-level data obtained from passive trackers has the potential to help in determining patients’ disease state and progression.

Dyslipidemia / High Cholesterol: PGHD delivers valuable insights for cholesterol management

Person-generated health data (PGHD) can lead to deeper understanding and help inform better treatment options.

Alzheimers Disease and MCI — Cognitive impairment & PGHD: Insights for better management

Person-generated health data (PGHD) shows promise in detecting cognitive impairment & informing therapies.

Carlie Cherry, Aniya Abbott